IMMUNODIAGNOSTICS  |  IMMUNOMONITORINGImmuQuad Biotech   ·   Contact@ImmuQuad.com

Applications in lymphoid hematologic malignancies

Seq-MRD is designed for diseases in which a malignant B- or T-cell clone carries a trackable immune receptor rearrangement.

Patient-specific immune receptor clone tracking
Potential use settings

From baseline identification to post-treatment surveillance

B

B-cell acute lymphoblastic leukemia

IGH and, where appropriate, light-chain rearrangements can provide patient-specific markers for treatment-response and follow-up monitoring.

T

T-cell acute lymphoblastic leukemia

TRB and TRG rearrangements can be evaluated as molecular tracking targets in T-lineage disease.

CLL

Chronic lymphocytic leukemia

Clonal immunoglobulin rearrangements may support molecular monitoring in selected clinical or research settings.

MM

Multiple myeloma

Baseline identification and high-depth follow-up can support assessment of residual clonal plasma-cell disease when a suitable marker is found.

B/T

B- and T-cell lymphomas

Selected lymphoma subtypes may be evaluated using disease-associated Ig or TCR rearrangements, depending on sample type and clonality.

CT

Clinical trials & cell therapy

Longitudinal molecular endpoints can support translational studies, CAR-T monitoring programs and drug-development workflows.

Specimen strategy

Match the sample to the clinical question

A baseline sample with adequate disease burden is essential for marker discovery. Follow-up specimen selection should reflect disease biology, treatment protocol and the laboratory’s validated procedures.

Testing stageTypical purposePossible specimensKey consideration
Baseline clonalityFind dominant disease-associated BCR/TCR markersBone marrow, blood, tissue, extracted DNAUse a specimen with sufficient malignant-cell burden
On-treatment MRDMeasure depth and kinetics of responseBone marrow or blood, depending on disease/protocolCollect at protocol-defined time points
Post-treatment follow-upTrack known markers and screen for emerging clonesBone marrow, blood or other validated specimenInterpret trends with clinical and laboratory context
Clinical trialGenerate standardized molecular endpointsProtocol-specified serial specimensPredefine sampling, input, thresholds and data handling
Collaboration models

Testing services and study support

  • Clinical-laboratory testing collaboration.
  • Investigator-initiated studies and translational research.
  • Biopharma clinical trials and companion monitoring.
  • Assay-development, data-analysis and reporting support.

Planning information

To discuss a project, provide the disease, intended use, sample types, expected number of patients and time points, geographic market and any protocol-specific sensitivity or reporting requirements.

Start a discussion

Discuss a Seq-MRD project with ImmuQuad

Clinical testing, translational research, clinical trials and biopharma collaborations.

Contact our team